NEU 3.50% $14.05 neuren pharmaceuticals limited

Totally agree. After having gone through Neuren analysts reports...

  1. 407 Posts.
    lightbulb Created with Sketch. 1256
    Totally agree. After having gone through Neuren analysts reports in detail many times over the years I found all riddled with serious errors and non sequiturs.

    Came to the conclusion analysts valuations are generally worthless. You get what you pay for I guess.

    DYOR
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.